UPB

Upstream Bio, Inc. Common Stock

29.77

USD

UPB Earnings Reports

Positive Surprise Ratio

UPB beat 1 of 5 last estimates.

20%

Next Report

Date of Next Report

Mar 10, 2026

Estimate for Q4 25 (Revenue/ EPS)

$614.41K

-$0.68

Implied change from Q3 25 (Revenue/ EPS)

-10.04%

+7.94%

Implied change from Q4 24 (Revenue/ EPS)

+0.23%

-57.23%

Upstream Bio, Inc. Common Stock earnings per share and revenue

On Nov 05, 2025, UPB reported earnings of -0.63 USD per share (EPS) for Q3 25, beating the estimate of -0.78 USD, resulting in a 20.23% surprise. Revenue reached 683.00 thousand, compared to an expected 651.45 thousand, with a 4.84% difference. The market reacted with a -4.27% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 9 analysts forecast an EPS of -0.68 USD, with revenue projected to reach 614.41 thousand USD, implying an increase of 7.94% EPS, and decrease of -10.04% in Revenue from the last quarter.

FAQ

What were Upstream Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Upstream Bio, Inc. Common Stock reported EPS of -$0.63, beating estimates by 20.23%, and revenue of $683.00K, 4.84% above expectations.

How did the market react to Upstream Bio, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -4.27%, changed from $25.04 before the earnings release to $23.97 the day after.

When is Upstream Bio, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 10, 2026.

What are the forecasts for Upstream Bio, Inc. Common Stock's next earnings report?

Based on 9 analysts, Upstream Bio, Inc. Common Stock is expected to report EPS of -$0.68 and revenue of $614.41K for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.